<html><head></head><body><text>
<title></title>
<p style="margin: 0"> </p>
<!-- Field: Rule-Page --><div style="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><div style="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid"> </div></div><!-- Field: /Rule-Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-size: 14pt"><b>UNITED
STATES</b></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-size: 14pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-size: 12pt"><b>WASHINGTON,
D.C. 20549</b></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-size: 18pt"><b>SCHEDULE
14A</b></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Proxy Statement Pursuant to Section 14(a)
of the Securities Exchange Act of 1934</b></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tbody><tr>
<td colspan="2"> </td>
<td> </td></tr>
<tr style="vertical-align: top">
<td colspan="2" style="text-align: justify">Filed by the Registrant</td>
<td style="text-align: justify"><font style="font-family: Wingdings"><b>x</b></font></td></tr>
<tr style="vertical-align: top">
<td colspan="2" style="text-align: justify">Filed by a Party other than the Registrant</td>
<td style="text-align: justify"><font style="font-family: Wingdings">¨</font></td></tr>
<tr>
<td> </td>
<td colspan="2"> </td></tr>
<tr style="vertical-align: top">
<td colspan="3" style="text-align: justify">Check the appropriate box:</td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify"><font style="font-family: Wingdings">¨</font></td>
<td colspan="2" style="text-align: justify">Preliminary Proxy Statement</td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify"><font style="font-family: Wingdings">¨</font></td>
<td colspan="2" style="text-align: justify"><b>Confidential, For Use of the Commission Only (as Permitted by Rule 14a-6(e)(2))</b></td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify"><font style="font-family: Wingdings">x</font></td>
<td colspan="2" style="text-align: justify">Definitive Proxy Statement</td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify"><font style="font-family: Wingdings">¨</font></td>
<td colspan="2" style="text-align: justify">Definitive Additional Materials</td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify"><font style="font-family: Wingdings">¨</font></td>
<td colspan="2" style="text-align: justify">Soliciting Material Pursuant to § 240.14a-12</td></tr>
<tr>
<td style="width: 5%"> </td>
<td style="width: 35%"> </td>
<td style="width: 60%"> </td></tr>
</tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-size: 24pt"><b><u>DPW
HOLDINGS, INC.</u></b></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name of Registrant as Specified in its
Charter)</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name of Person(s) Filing Proxy Statement,
if other than the Registrant)</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tbody><tr style="vertical-align: top">
<td colspan="2">Payment of Filing Fee (Check the appropriate box):</td></tr>
<tr style="vertical-align: top">
<td style="width: 1%"><font style="font-family: Wingdings"><b>x</b></font></td>
<td style="width: 99%">No fee required</td></tr>
<tr style="vertical-align: top">
<td><font style="font-family: Wingdings">¨</font></td>
<td>Fee computed on table below per Exchange Act Rules 14a-6(i) (1) and 0-11. </td></tr>
</tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tbody><tr style="vertical-align: top">
<td style="width: 1%"> </td>
<td style="width: 1%">(1)</td>
<td style="border-bottom: Black 1pt solid; width: 98%; text-align: justify">Title of each class of securities to which transaction applies: </td></tr>
<tr style="vertical-align: top">
<td> </td>
<td>(2)</td>
<td style="border-bottom: Black 1pt solid; text-align: justify">Aggregate number of securities to which transaction applies: </td></tr>
<tr style="vertical-align: top">
<td> </td>
<td>(3)</td>
<td style="border-bottom: Black 1pt solid; text-align: justify">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): </td></tr>
<tr style="vertical-align: top">
<td> </td>
<td>(4)</td>
<td style="border-bottom: Black 1pt solid; text-align: justify">Proposed maximum aggregate value of transaction: </td></tr>
<tr style="vertical-align: top">
<td> </td>
<td>(5)</td>
<td style="border-bottom: Black 1pt solid; text-align: justify">Total fee paid: </td></tr>
</tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tbody><tr style="vertical-align: top">
<td style="width: 1%"><font style="font-family: Wingdings">¨</font> </td>
<td style="width: 99%">Fee paid previously with preliminary materials:</td></tr>
<tr style="vertical-align: top">
<td> </td>
<td> </td></tr>
<tr style="vertical-align: top">
<td><font style="font-family: Wingdings">¨</font></td>
<td>Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.</td></tr>
</tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tbody><tr style="vertical-align: top">
<td style="width: 1%"> </td>
<td style="width: 1%">(1)</td>
<td style="width: 98%; text-align: justify">Amount Previously Paid: </td></tr>
<tr style="vertical-align: top">
<td> </td>
<td>(2)</td>
<td style="text-align: justify">Form, Schedule or Registration Statement No.: </td></tr>
<tr style="vertical-align: top">
<td> </td>
<td>(3)</td>
<td style="text-align: justify">Filing Party: </td></tr>
<tr style="vertical-align: top">
<td> </td>
<td>(4)</td>
<td style="text-align: justify">Date Filed: </td></tr>
</tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p>
<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid"> </div></div><!-- Field: /Rule-Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
<!-- Field: Page; Sequence: 1 -->
<div style="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"> </td><td style="width: 33%; text-align: right"> </td></tr></tbody></table></div>
<div style="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tbody><tr><td style="text-align: center; width: 100%"> </td></tr></tbody></table></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: red"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>DEFINITIVE PROXY STATEMENT</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: red"><b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>DATED MAY 18, 2020</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>DPW HOLDINGS, INC.</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>201 Shipyard Way, Suite E</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Newport Beach, California 92663</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Telephone: (949) 444-5464</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTICE OF SPECIAL MEETING OF STOCKHOLDERS</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>To Be Held on June 8, 2020</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> We cordially invite you to attend
the Special Meeting of Stockholders of DPW Holdings, Inc. (“<b>DPW</b>” or the “<b>Company</b>”). Due to
the emerging public health impact of the coronavirus outbreak (COVID-19) and out of concern for the health and well-being of our
employees and stockholders, NOTICE IS HEREBY GIVEN that the location, date and time of the Special Meeting of Stockholders (the
“<b>Special Meeting</b>”) of DPW Holdings, Inc. (the “<b>Company</b>”) has been changed and will be held
on Monday, June 8, 2020 at 9:00 A.M. Pacific Time. In light of public health concerns, the Special Meeting will be held in
a virtual meeting format only. You will not be able to attend the Special Meeting in person.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To access the virtual meeting please click
the Virtual Shareholder Meeting link: <u>www.meetingcenter.io/266742656</u>. To login to the virtual meeting you have two option:
Join as a “Guest” or Join as a “Shareholder”. If you join as a “Shareholder” you will be required
to have a control number and password. The password for the meeting is DPW2020.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Details regarding logging
onto and attending the meeting over the website and the business to be conducted are described in the Proxy Card included with
this Proxy Statement.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Special Meeting
will be held for the following purposes:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tbody><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><font style="font-family: Symbol">·</font></td><td style="text-align: justify">To approve, pursuant to Rule 713 of the NYSE American, the issuance of shares of the Corporation’s
Class A common stock, par value $0.001 per share (“<b>Common Stock</b>”) to Esousa Holdings LLC (“<b>Esousa</b>”),
in accordance with the Master Exchange Agreement dated February 10, 2020, and the exercise of warrants issued in connection therewith;</td></tr></tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tbody><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><font style="font-family: Symbol">·</font></td><td style="text-align: justify">To approve the exercise of warrants issued or issuable to Esousa to purchase up to an aggregate
of 2,000,000 shares of Common Stock, issued in connection with certain term promissory notes in an aggregate amount of up to $2,000,000;</td></tr></tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tbody><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><font style="font-family: Symbol">·</font></td><td style="text-align: justify">To approve the conversion of a $1,000,000 Convertible Promissory Note issued on February 5,
2020 (the “<b>Ault Note</b>”), to Ault &amp; Company, Inc., which is convertible into 717,241 shares of Common Stock
at $1.45 per share (which figure presumes conversion of principal and accrued but unpaid interest as of August 5, 2020, the maturity
date of the Ault Note), in order to comply with the listing rules the NYSE American;</td></tr></tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"> </p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tbody><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><font style="font-family: Symbol">·</font></td><td style="text-align: justify">To ratify the appointment of Marcum LLP, as the Company’s independent registered public accounting
firm for the fiscal year ending December 31, 2020; and</td></tr></tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tbody><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><font style="font-family: Symbol">·</font></td><td style="text-align: justify">The transaction of such other business as may properly come before the Special Meeting or any adjournments
or postponements thereof.</td></tr></tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The accompanying proxy
statement sets forth additional information regarding the Special Meeting, and provides you with detailed information regarding
the business to be considered at the Special Meeting. We encourage you to read the proxy statement carefully and in its entirety.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Only stockholders of
record at the close of business on May 11, 2020, the record date for the Special Meeting, will be entitled to vote at the Special
Meeting or any adjournments or postponements thereof. The proxy materials will be mailed to stockholders on or about May 20, 2020.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
<!-- Field: Page; Sequence: 2 -->
<div style="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"> </td><td style="width: 33%; text-align: right"> </td></tr></tbody></table></div>
<div style="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tbody><tr><td style="text-align: center; width: 100%"> </td></tr></tbody></table></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>Important Notice
Regarding the Availability of Proxy Materials for the Special Meeting of Stockholders to be held on June 8, 2020:</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>This Notice of Special Meeting of Stockholders
and the accompanying Proxy Statement are available</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>on the Internet at www.envisionreports.com/DPW.</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">BY ORDER OF THE BOARD OF DIRECTORS</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Milton C. Ault III</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chief Executive Officer and Chairman of the Board</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">May 18, 2020</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><u>HOW TO VOTE</u>:
Your vote is important. Whether or not you plan to virtually attend the Special Meeting, we hope you will vote as soon as possible
by either (1) mailing your completed and signed proxy card(s) to DPW Holdings, Inc., 201 Shipyard Way, Newport Beach, CA 92663,
Attention: Corporate Secretary, (2) calling the toll-free number printed on your proxy card(s) and following the recorded instructions
or (3) visiting the website indicated on your proxy card(s) and following the on-line instructions. You may revoke a previously
submitted proxy at any time prior to the Special Meeting. If you decide to attend the Special Meeting and wish to change your proxy
vote, you may do so automatically by voting at the Special Meeting.</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><b></b></p>
<!-- Field: Page; Sequence: 3 -->
<div style="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"> </td><td style="width: 33%; text-align: right"> </td></tr></tbody></table></div>
<div style="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tbody><tr><td style="text-align: center; width: 100%"> </td></tr></tbody></table></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><b></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tbody><tr>
<td style="white-space: nowrap; vertical-align: top; width: 95%; border-bottom: #4BACC6 1pt solid; text-align: center"><b>TABLE OF CONTENTS</b></td>
<td style="vertical-align: bottom; width: 5%; border-bottom: #4BACC6 1pt solid; text-align: center"> </td></tr>
<tr>
<td style="white-space: nowrap; vertical-align: top; border-bottom: #4BACC6 1pt solid"> </td>
<td style="vertical-align: bottom; border-bottom: #4BACC6 1pt solid; text-align: center"><b>Page</b></td></tr>
<tr style="background-color: #CCEEFF">
<td style="white-space: nowrap; vertical-align: top; text-align: justify"><b>INFORMATION CONCERNING THE SPECIAL MEETING</b></td>
<td style="vertical-align: bottom; text-align: right">1</td></tr>
<tr style="background-color: white">
<td style="white-space: nowrap; vertical-align: top; text-align: justify"><b>QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING</b></td>
<td style="vertical-align: bottom; text-align: right">3</td></tr>
<tr style="background-color: #CCEEFF">
<td style="white-space: nowrap; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>PROPOSAL NO. 1: APPROVAL, PURSUANT TO
        NYSE AMERICAN LISTING RULE 713, OF THE ISSUANCE OF</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>SHARES OF OUR COMMON STOCK TO ESOUSA</b></p></td>
<td style="vertical-align: bottom; text-align: right">8</td></tr>
<tr style="background-color: white">
<td style="white-space: nowrap; vertical-align: top; text-align: justify"><b>Overview of Exchange Agreement</b></td>
<td style="vertical-align: bottom; text-align: right">8</td></tr>
<tr style="background-color: #CCEEFF">
<td style="white-space: nowrap; vertical-align: top; text-align: justify"><b>Stockholder Approval Requirement</b></td>
<td style="vertical-align: bottom; text-align: right">9</td></tr>
<tr style="background-color: white">
<td style="white-space: nowrap; vertical-align: top; text-align: justify"><b>Reasons for Transaction</b></td>
<td style="vertical-align: bottom; text-align: right">10</td></tr>
<tr style="background-color: #CCEEFF">
<td style="white-space: nowrap; vertical-align: top; text-align: justify"><b>Effect on Current Stockholders; Dilution</b></td>
<td style="vertical-align: bottom; text-align: right">10</td></tr>
<tr>
<td style="white-space: nowrap; vertical-align: top; text-align: justify"><b>Required Vote and Board Recommendation</b></td>
<td style="vertical-align: bottom; text-align: right">10</td></tr>
<tr style="background-color: #CCEEFF">
<td style="white-space: nowrap; vertical-align: top; text-align: justify"><b>PROPOSAL NO. 2: APPROVAL OF THE EXERCISE OF WARRANTS TO PURCHASE UP TO 2,000,000 SHARES <br/>
OF COMMON STOCK IN ORDER TO COMPLY WITH RULE 713 OF THE NYSE AMERICAN</b></td>
<td style="vertical-align: bottom; text-align: right">11</td></tr>
<tr style="background-color: white">
<td style="white-space: nowrap; vertical-align: top; text-align: justify"><b>Terms of the Transaction</b></td>
<td style="vertical-align: bottom; text-align: right">11</td></tr>
<tr style="background-color: #CCEEFF">
<td style="white-space: nowrap; vertical-align: top; text-align: justify"><b>Description of the Warrants</b></td>
<td style="vertical-align: bottom; text-align: right">11</td></tr>
<tr style="background-color: white">
<td style="white-space: nowrap; vertical-align: top; text-align: justify"><b>Why the Company Needs Stockholder Approval</b></td>
<td style="vertical-align: bottom; text-align: right">11</td></tr>
<tr style="background-color: #CCEEFF">
<td style="white-space: nowrap; vertical-align: top; text-align: justify"><b>Effect of Proposal on Current Stockholders</b></td>
<td style="vertical-align: bottom; text-align: right">11</td></tr>
<tr style="background-color: white">
<td style="white-space: nowrap; vertical-align: top; text-align: justify"><b>Required Vote and Board Recommendation</b></td>
<td style="vertical-align: bottom; text-align: right">11</td></tr>
<tr style="background-color: #CCEEFF">
<td style="white-space: nowrap; vertical-align: top">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>PROPOSAL NO. 3: APPROVAL OF THE CONVERSION
        OF A $1,000,000 CONVERTIBLE PROMISSORY NOTE<br/>
        INTO 717,241 SHARES OF COMMON STOCK IN ORDER TO COMPLY WITH RULE 713 OF THE NYSE</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>AMERICAN</b></p></td>
<td style="vertical-align: bottom; text-align: right">12</td></tr>
<tr style="background-color: white">
<td style="white-space: nowrap; vertical-align: top; text-align: justify"><b>Terms of the Transaction</b></td>
<td style="vertical-align: bottom; text-align: right">12</td></tr>
<tr style="background-color: #CCEEFF">
<td style="white-space: nowrap; vertical-align: top; text-align: justify"><b>Why the Company Needs Stockholder Approval</b></td>
<td style="vertical-align: bottom; text-align: right">12</td></tr>
<tr style="background-color: white">
<td style="white-space: nowrap; vertical-align: top; text-align: justify"><b>Effect of Proposal on Current Stockholders</b></td>
<td style="vertical-align: bottom; text-align: right">12</td></tr>
<tr style="background-color: #CCEEFF">
<td style="white-space: nowrap; vertical-align: top; text-align: justify"><b>Further Information</b></td>
<td style="vertical-align: bottom; text-align: right">12</td></tr>
<tr style="background-color: white">
<td style="white-space: nowrap; vertical-align: top; text-align: justify"><b>Required Vote and Board Recommendation</b></td>
<td style="vertical-align: bottom; text-align: right">12</td></tr>
<tr style="background-color: #CCEEFF">
<td style="white-space: nowrap; vertical-align: top; text-align: justify"><b>PROPOSAL NO. 4: RATIFICATION OF APPOINTMENT OF OUR INDEPENDENT REGISTERED PUBLIC </b><br/>
<b>ACCOUNTING FIRM</b></td>
<td style="vertical-align: bottom; text-align: right">13</td></tr>
<tr>
<td style="white-space: nowrap; vertical-align: top; text-align: justify">Review of the Company’s Audited Financial Statements for the Fiscal Year Ended December 31, 2018</td>
<td style="vertical-align: bottom; text-align: right">13</td></tr>
<tr style="background-color: #CCEEFF">
<td style="white-space: nowrap; vertical-align: top; text-align: justify">Fees Paid to Auditors</td>
<td style="vertical-align: bottom; text-align: right">13</td></tr>
<tr>
<td style="white-space: nowrap; vertical-align: top; text-align: justify">Pre-Approval Policies and Procedures</td>
<td style="vertical-align: bottom; text-align: right">13</td></tr>
<tr style="background-color: #CCEEFF">
<td style="white-space: nowrap; vertical-align: top; text-align: justify"><b>REPORT OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS</b></td>
<td style="vertical-align: bottom; text-align: right">14</td></tr>
<tr>
<td style="white-space: nowrap; vertical-align: top; text-align: justify">Required Vote and Board Recommendation </td>
<td style="vertical-align: bottom; text-align: right">14</td></tr>
<tr style="background-color: #CCEEFF">
<td style="white-space: nowrap; vertical-align: top; text-align: justify"><b>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</b></td>
<td style="vertical-align: bottom; text-align: right">15</td></tr>
<tr style="background-color: white">
<td style="white-space: nowrap; vertical-align: top; text-align: justify"><b>OTHER BUSINESS</b></td>
<td style="text-align: right; vertical-align: bottom">16</td></tr>
</tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
<!-- Field: Page; Sequence: 4; Options: NewSection -->
<div style="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></tbody></table></div>
<div style="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tbody><tr><td style="text-align: center; width: 100%"> </td></tr></tbody></table></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>DPW HOLDINGS, INC.</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>201 Shipyard Way, Suite E</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Newport Beach, California 92663</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Telephone: (949) 444-5464</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>DEFINITIVE PROXY STATEMENT</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FOR THE SPECIAL MEETING OF STOCKHOLDERS</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>TO BE HELD ON JUNE 8, 2020</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INFORMATION CONCERNING THE SPECIAL MEETING</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>General</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The enclosed proxy
is solicited by the Board of Directors (the “<b>Board</b>”) of DPW Holdings, Inc. (the “<b>Company</b>”
or “<b>DPW</b>”), for use at a Special Meeting of the Company’s stockholders (the “<b>Special Meeting</b>”)
to be held in virtual format on June 8, 2020 at 9:00 PT and at any adjournments thereof. Whether or not you expect to attend the
Special Meeting, please vote your shares as promptly as possible to ensure that your vote is counted. The proxy materials will
be furnished to stockholders on or about May 20, 2020.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In light of public
health concerns, the Special Meeting will be held in a virtual meeting format only. You will not be able to attend the Special
Meeting in person. To access the virtual meeting please click the Virtual Shareholder Meeting link: <u>www.meetingcenter.io/266742656</u>.
To login to the virtual meeting you have two option: Join as a “Guest” or Join as a “Shareholder”. If you
join as a “Shareholder” you will be required to have a control number and password. The password for the meeting is
DPW2020.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Action to be taken under Proxy</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless otherwise directed
by the giver of the proxy, the persons named in the form of proxy, namely, Milton C. “Todd” Ault, III, the Company’s
Chairman and Chief Executive Officer, and William B. Horne, the Company’s Chief Financial Officer, or either one of them
who acts, will vote:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tbody><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><font style="font-family: Symbol">·</font></td><td style="text-align: justify">FOR approval, pursuant to Rule 713 of the NYSE American, of the issuance of shares of the Corporation’s
Class A common stock, par value $0.001 per share (“<b>Common Stock</b>”) to Esousa Holdings LLC (“<b>Esousa</b>”),
in accordance with the Master Exchange Agreement dated February 10, 2020, and the exercise of warrants issued in connection therewith;</td></tr></tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tbody><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><font style="font-family: Symbol">·</font></td><td style="text-align: justify">FOR approval of the exercise of warrants issued or issuable to Esousa to purchase up to an aggregate
of 2,000,000 shares of Common Stock, issued in connection with certain term promissory notes in an aggregate amount of up to $2,000,000;</td></tr></tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tbody><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><font style="font-family: Symbol">·</font></td><td style="text-align: justify">FOR approval of approve the conversion of a $1,000,000 Convertible Promissory Note issued
on February 5, 2020 (the “<b>Ault Note</b>”), to Ault &amp; Company, Inc., which is convertible into 717,241 shares
of Common Stock at $1.45 per share (which figure presumes conversion of principal and accrued but unpaid interest as of August
5, 2020, the maturity date of the Ault Note), in order to comply with the listing rules the NYSE American;</td></tr></tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"> </p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tbody><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><font style="font-family: Symbol">·</font></td><td style="text-align: justify">To ratify the appointment of Marcum LLP, as the Company’s independent registered public accounting
firm for the fiscal year ending December 31, 2020; and</td></tr></tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tbody><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><font style="font-family: Symbol">·</font></td><td style="text-align: justify">In their discretion, on the transaction of such other matters as may properly come before the meeting
or any adjournment thereof.</td></tr></tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">By submitting your
proxy (via the Internet, telephone or mail), you authorize Milton C. “Todd” Ault, III, the Company’s Chairman
and Chief Executive Officer, and William B. Horne, the Company’s Chief Financial Officer, to represent you and vote your
shares at the Special Meeting in accordance with your instructions. They also may vote your shares to adjourn the Special Meeting
and will be authorized to vote your shares at any postponements or adjournments of the Special Meeting.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
<!-- Field: Page; Sequence: 5 -->
<div style="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"> </td><td style="width: 33%; text-align: right"> </td></tr></tbody></table></div>
<div style="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tbody><tr><td style="text-align: center; width: 100%"> </td></tr></tbody></table></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>YOUR VOTE IS IMPORTANT.
WHETHER OR NOT YOU PLAN TO ATTEND THE SPECIAL MEETING, PLEASE PROMPTLY VOTE YOUR SHARES OVER THE INTERNET, BY TELEPHONE OR BY MAIL.</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Who is Entitled to Vote; Vote Required;
Quorum</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of the record date
of May 11, 2020 (the “<b>Record Date</b>”), there were 5,771,634 shares of Common Stock issued and outstanding; 7,040
shares of Series A Cumulative Redeemable Perpetual Preferred Stock issued and outstanding and 125,000 shares of Series B Convertible
Preferred Stock issued and outstanding, which constitute all of the outstanding capital stock of the Company. Stockholders are
entitled to one vote for each share of Common Stock held by them. The 125,000 shares of Series B Convertible Preferred Stock carry
the voting power of 0.04% of all votes entitled to be voted at the Special Meeting. The up to 10,000,000 shares of common
stock issuable upon exercise of warrants issuable to Esousa will, assuming (i) approval of Proposal 2 and the (ii) the issuance
of promissory notes in an aggregate amount of $2,000,000, carry the voting power of a presently indeterminate percentage of all
votes entitled to be voted at any annual or special meeting of stockholders of our Company or action by written consent of our
stockholders but will not carry any voting rights at the Special Meeting. The up to 717,241 shares of common stock issuable upon
conversion of the note issued to Ault &amp; Company (the “<b>Ault Note</b>”) will, assuming approval of Proposal 3,
carry the voting power of 11.1% of all votes entitled to be voted at any annual or special meeting of stockholders of our Company
or action by written consent of our stockholders but will not carry any voting rights at the Special Meeting; the figure 717,241
assumes the Ault Note will be converted at maturity, when its principal and interest will amount to $1,040,000.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A majority of the 5,771,634
outstanding shares of Common Stock on the Record Date will constitute a quorum at the Special Meeting.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Brokers holding shares
of record for customers generally are not entitled to vote on “non-routine” matters, unless they receive voting instructions
from their customers. As used herein, “uninstructed shares” means shares held by a broker who has not received such
instructions from its customers on a proposal. A “broker non-vote” occurs when a nominee holding uninstructed shares
for a beneficial owner does not vote on a particular proposal because the nominee does not have discretionary voting power with
respect to that non-routine matter. In connection with the treatment of abstentions and broker non-votes, all but one of the proposals
at this are considered “non-routine” matters, and brokers are not entitled to vote uninstructed shares with respect
to these proposals. Only the proposal to ratify the appointment of Marcum LLP, as the Company’s independent registered public
accounting firm, is a routine matter that brokers are entitled to vote upon without receiving instructions.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Determination of whether
a matter specified in the Notice of Special Meeting of Stockholders has been approved will be determined as follows:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tbody><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><font style="font-family: Symbol">·</font></td><td style="text-align: justify">For each matter specified in the Notice of Special Meeting of Stockholders, the affirmative vote
of a majority of the shares of Common Stock present at the meeting in person or by proxy and entitled to vote on such matter is
required for approval. Abstentions will be considered shares present by proxy and entitled to vote and, therefore, will have the
effect of a vote against the matter. Broker non-votes will be considered shares not present for this purpose and will have no effect
on the outcome of the vote.</td></tr></tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Abstentions and broker
non-votes will be counted for purposes of determining whether a quorum is present for the Special Meeting.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>
<!-- Field: Page; Sequence: 6; Options: NewSection -->
<div style="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Value: 2; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></tbody></table></div>
<div style="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tbody><tr><td style="text-align: center; width: 100%"> </td></tr></tbody></table></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>QUESTIONS AND ANSWERS ABOUT THESE PROXY
MATERIALS AND VOTING</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>What is the purpose of the Special Meeting?</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At the Special Meeting, the stockholders
will be asked:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tbody><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">1.</td><td style="text-align: justify">To approve, pursuant to Rule 713 of the NYSE American, the issuance of shares of the Corporation’s
Class A common stock, par value $0.001 per share (“<b>Common Stock</b>”) to Esousa Holdings LLC (“<b>Esousa</b>”),
in accordance with the Master Exchange Agreement dated February 10, 2020, and the exercise of warrants issued in connection therewith;</td></tr></tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tbody><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">2.</td><td style="text-align: justify">To approve the exercise of warrants issued or issuable to Esousa to purchase up to an aggregate
of 2,000,000 shares of Common Stock, issued in connection with certain term promissory notes in an aggregate amount of up to $2,000,000;</td></tr></tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tbody><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">3.</td><td style="text-align: justify">To approve the conversion of a $1,000,000 Convertible Promissory Note issued on February 5,
2020 (the “<b>Ault Note</b>”), to Ault &amp; Company, Inc., which is convertible into 717,241 shares of Common Stock
at $1.45 per share (which figure presumes conversion of principal and accrued but unpaid interest as of August 5, 2020, the maturity
date of the Ault Note), in order to comply with the listing rules the NYSE American;</td></tr></tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"> </p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tbody><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">4.</td><td style="text-align: justify">To ratify the appointment of Marcum LLP, as the Company’s independent registered public accounting
firm for the fiscal year ending December 31, 2020; and</td></tr></tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tbody><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in">5.</td><td style="text-align: justify">The transaction of such other business as may properly come before the Special Meeting or any adjournments
or postponements thereof.</td></tr></tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Who is entitled to vote?</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Record Date for the Special Meeting
is May 11, 2020. Only stockholders of record at the close of business on that date are entitled to vote at the Special Meeting.
The only class of stock entitled to be voted at the meeting is our Common Stock and Series B Convertible Preferred Stock. On the
Record Date, there were 5,771,634 shares of Common Stock outstanding; and 125,000 shares of Series B Convertible Preferred Stock
issued and outstanding and entitled to vote. The issued and outstanding shares of Series B Convertible Preferred Stock carry the
voting power of 0.04% of the shares of Common Stock.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Why am I receiving these materials?</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have sent you these proxy materials
because the Board of the Company is soliciting your proxy to vote at the Special Meeting. According to our records, you were a
stockholder of the Company as of the end of business on May 11, 2020, the Record Date for the Special Meeting.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You are invited to vote on the proposals
described in this proxy statement.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company intends to mail these proxy
materials on or about May 20, 2020 to the stockholders of record on the Record Date.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>What is included in these materials?</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These materials include:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tbody><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><font style="font-family: Symbol">·</font></td><td style="text-align: justify">the Notice of Special Meeting of Stockholders; and</td></tr></tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tbody><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><font style="font-family: Symbol">·</font></td><td style="text-align: justify">this Proxy Statement for the Special Meeting.</td></tr></tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
<!-- Field: Page; Sequence: 7 -->
<div style="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></tbody></table></div>
<div style="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tbody><tr><td style="text-align: center; width: 100%"> </td></tr></tbody></table></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>What is the proxy card?</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The proxy card enables you to appoint Milton
C. “Todd” Ault, III, the Company’s Chairman and Chief Executive Officer, and William B. Horne, the Company’s
Chief Financial Officer, as your representative at the Special Meeting. By completing and returning a proxy card, you are authorizing
these individuals to vote your shares at the Special Meeting in accordance with your instructions on the proxy card. This way,
your shares will be voted whether or not you log in to the Special Meeting.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Can I view these proxy materials over
the Internet?</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yes. The Notice of Special Meeting, this
Proxy Statement and accompanying proxy card are available at www.envisionreports.com/DPW.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>How can I attend the Special Meeting?</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Special Meeting will be a completely
virtual meeting of stockholders, which will be conducted exclusively by webcast. You are entitled to participate in the Special
Meeting only if you were a stockholder of the Company as of the close of business on the Record Date, or if you hold a valid proxy
for the Special Meeting. No physical meeting will be held.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You will be able to attend the Special
Meeting online by visiting <u>www.meetingcenter.io/266742656</u>. To login to the virtual meeting you have two option: Join as
a “Guest” or Join as a “Shareholder”. If you join as a “Shareholder” you will be required to
have a control number and password. You also will be able to vote your shares online by attending the Special Meeting by webcast.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To participate in the Special Meeting,
you will need to review the information included on your Notice, on your proxy card or on the instructions that accompanied your
proxy materials. The password for the meeting is DPW2020.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If you hold your shares through an intermediary,
such as a bank or broker, you must register in advance using the instructions below.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The online meeting will begin promptly
at 9:00 AM PT. We encourage you to access the meeting prior to the start time leaving ample time for the check in. Please follow
the registration instructions as outlined in this proxy statement.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>How do I register to attend the Special
Meeting virtually on the Internet?</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -38pt"><b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If you are a registered shareholder (i.e.,
you hold your shares through our transfer agent, Computershare), you do not need to register to attend the Special Meeting virtually
on the Internet. Please follow the instructions on the notice or proxy card that you received.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If you hold your shares through an intermediary,
such as a bank or broker, you must register in advance to attend the Special Meeting virtually on the Internet.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To register to attend the Special Meeting
online by webcast you must submit proof of your proxy power (legal proxy) reflecting your DPW holdings along with your name and
email address to Computershare. Requests for registration must be labeled as “Legal Proxy” and be received no later
than 5:00 p.m., Eastern Time, on June 5, 2020.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You will receive a confirmation of your
registration by email after we receive your registration materials.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Requests for registration should be directed
to us at the following:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">By email:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Forward the email from your broker, or
attach an image of your legal proxy, to legalproxy@computershare.com</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">By mail:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Computershare<br/>
Legal Proxy<br/>
P.O. Box 43001<br/>
Providence, RI 02940-3001</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Why are you holding a virtual meeting
instead of a physical meeting?</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are excited to embrace the latest technology
to provide expanded access, improved communication and cost savings for our stockholders and the Company. We believe that hosting
a virtual meeting will enable more of our stockholders to attend and participate in the meeting since our stockholders can participate
from any location around the world with Internet access.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>
<!-- Field: Page; Sequence: 8 -->
<div style="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></tbody></table></div>
<div style="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tbody><tr><td style="text-align: center; width: 100%"> </td></tr></tbody></table></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>How do I vote?</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Either (1) mail your completed and signed
proxy card(s) to DPW Holdings, Inc., 201 Shipyard Way, Newport Beach, CA 92663, Attention: Corporate Secretary, (2) call the toll-free
number printed on your proxy card(s) and follow the recorded instructions or (3) visit the website indicated on your proxy card(s)
and follow the on-line instructions. If you are a registered stockholder and attend the Special Meeting, then you may deliver your
completed proxy card(s) or vote pursuant to the instructions on the proxy card. If your shares are held by your broker or bank,
in “street name”, then you will receive a form from your broker or bank seeking instructions as to how your shares
should be voted. If you do not instruct your broker or bank how to vote, then your broker or bank will vote your shares if it has
discretionary power to vote on a particular matter.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Am I entitled to vote if my shares are held in “street
name”?</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If your shares are held by a bank, brokerage
firm or other nominee, you are considered the “beneficial owner” of shares held in “street name.” If your
shares are held in street name, the proxy materials are being made available to you by your bank, brokerage firm or other nominee
(the “<b>record holder</b>”), along with voting instructions. As the beneficial owner, you have the right to direct
your record holder how to vote your shares, and the record holder is required to vote your shares in accordance with your instructions.
If you do not give instructions to your record holder, it will nevertheless be entitled to vote your shares in its discretion on
the ratification of the appointment of the independent registered public accounting firm (Proposal No. 4), but not on any other
proposal.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As the beneficial owner of shares, you
are invited to attend the Special Meeting. If you are a beneficial owner, however, you may not vote your shares at the Special
Meeting unless you obtain a legal proxy, executed in your favor, from the record holder of your shares.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>How many shares must be present to hold the Special Meeting?</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A quorum must be present at the meeting
for any business to be conducted. The presence at the meeting, (i) by logging in to www.meetingcenter.io/266742656<u>;</u> the
password is DPW2020, or (ii) by proxy, of the holders of a majority of the shares of capital stock outstanding on the Record Date
will constitute a quorum. Proxies received but marked as abstentions.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>What if a quorum is not present at the
Special Meeting?</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If a quorum is not present or represented
at the Special Meeting, the holders of a majority of the shares entitled to vote at the Special Meeting who are present in person
or represented by proxy, or the chairman of the meeting, may adjourn the Special Meeting until a quorum is present or represented.
The time and place of the adjourned meeting will be announced at the time the adjournment is taken, and no other notice will be
given.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Is there a deadline for submitting proxies
electronically or by telephone or mail?</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Proxies submitted electronically or by
telephone as described above must be received by 11:59 pm PT on June 5, 2020. Proxies submitted by mail should be received before
9:00 a.m. PT on June 8, 2020.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Can I revoke my proxy and change my
vote?</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You may change your vote at any time prior
to the taking of the vote at the meeting. If you are the stockholder of record, you may change your vote by (1) granting a new
proxy bearing a later date (which automatically revokes the earlier proxy) using any of the methods described above (and until
the applicable deadline for each method), (2) providing a written notice of revocation to the Company’s CEO at DPW Holdings,
Inc., 201 Shipyard Way, Newport Beach, CA 92663, prior to your shares being voted, or (3) virtually attending the Special Meeting
and voting in accordance with the instructions on the proxy card. Attendance at the Special Meeting will not cause your previously
granted proxy to be revoked unless you specifically so request. For shares you hold beneficially in street name, you may change
your vote by submitting new voting instructions to your broker, bank, trustee or nominee following the instructions they provided,
or, if you have obtained a legal proxy from your broker, bank, trustee or nominee giving you the right to vote your shares, by
attending the Special Meeting and voting.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Who can participate in the Special Meeting?</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Only stockholders eligible to vote or their
authorized representatives in possession of a valid control number will be admitted as participants to the Special Meeting.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>
<!-- Field: Page; Sequence: 9 -->
<div style="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></tbody></table></div>
<div style="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tbody><tr><td style="text-align: center; width: 100%"> </td></tr></tbody></table></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Will my vote be kept confidential?</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yes, your vote will be kept confidential
and not disclosed to the Company unless:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tbody><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in">•</td><td>required by law;</td></tr></tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tbody><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in">•</td><td>you expressly request disclosure on your proxy; or</td></tr></tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tbody><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in">•</td><td>there is a proxy contest.</td></tr></tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>How does the Board of Directors recommend I vote on the proposals?</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Board recommends that you vote your
shares as follows:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tbody><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><font style="font-family: Symbol">·</font></td><td style="text-align: justify">“<b>FOR</b>” approval, pursuant to Rule 713 of the NYSE American, of the issuance of
shares of the Corporation’s Class A common stock, par value $0.001 per share (“<b>Common Stock</b>”) to Esousa
Holdings LLC (“<b>Esousa</b>”), in accordance with the Master Exchange Agreement dated February 10, 2020, and the exercise
of warrants issued in connection therewith;</td></tr></tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tbody><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><font style="font-family: Symbol">·</font></td><td style="text-align: justify">“<b>FOR</b>” approval of the exercise of warrants issued or issuable to Esousa to purchase
up to an aggregate of 2,000,000 shares of Common Stock, issued in connection with certain term promissory notes in an aggregate
amount of up to $2,000,000; and</td></tr></tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tbody><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><font style="font-family: Symbol">·</font></td><td style="text-align: justify">“<b>FOR</b>” approval of approve the conversion of a $1,000,000 Convertible Promissory
Note issued on February 5, 2020 (the “<b>Ault Note</b>”), to Ault &amp; Company, Inc., which is convertible into 717,241
shares of Common Stock at $1.45 per share (which figure presumes conversion of principal and accrued but unpaid interest as of
August 5, 2020, the maturity date of the Ault Note), in order to comply with the listing rules the NYSE American; and</td></tr></tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"> </p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tbody><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><font style="font-family: Symbol">·</font></td><td style="text-align: justify">“<b>FOR</b>” approval of the appointment of Marcum LLP, as the Company’s independent
registered public accounting firm for the fiscal year ending December 31, 2020; and</td></tr></tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless you provide other instructions on
your proxy card, the persons named as proxy holders on the proxy card will vote in accordance with the recommendations of the Board
as set forth in this Proxy Statement.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>What if I do not specify how my shares are to be voted?</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If you return a signed and dated proxy
card without marking any voting selections, your shares will be voted in accordance with the Board’s recommended votes set
forth immediately above, and if any other matter is properly presented at the Special Meeting, your proxy holder (one of the individuals
named on your proxy card) will vote your shares using his best judgment.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Will any other business be conducted at the meeting?</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s bylaws require stockholders
to give advance notice of any proposal intended to be presented at the Special Meeting. We have not received any such notices.
Accordingly, the Company does not anticipate any additional business will be conducted at the Special Meeting.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>How many votes are needed to approve
each proposal?</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Approval of all matters requires the favorable
vote of a majority of the votes cast on the applicable matter at the Special Meeting.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>How will abstentions be treated?</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Abstentions will be treated as shares present
for quorum purposes and entitled to vote, and will have no effect on voting on any of the proposals.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>What are “broker non-votes”?</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Broker non-votes occur when a beneficial
owner of shares held in “street name” does not give instructions to the broker or nominee holding the shares as to
how to vote on matters deemed “non-routine.” Generally, if shares are held in street name, the beneficial owner of
the shares is entitled to give voting instructions to the broker or nominee holding the shares. If the beneficial owner does not
provide voting instructions, the broker or nominee can still vote the shares with respect to matters that are considered to be
“routine,” but not with respect to “non-routine” matters. Under the rules and interpretations of the New
York Stock Exchange, “non-routine” matters include director elections (whether contested or uncontested) and matters
involving a contest or a matter that may substantially affect the rights or privileges of stockholders.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>
<!-- Field: Page; Sequence: 10 -->
<div style="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></tbody></table></div>
<div style="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tbody><tr><td style="text-align: center; width: 100%"> </td></tr></tbody></table></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the treatment of abstentions
and broker non-votes, the proposals at this meeting to (i) approve the issuance of shares of Common Stock to Esousa, (ii) approve
the exercise of warrants issued or issuable to Esousa to purchase up to an aggregate of 2,000,000 shares of Common Stock and (iii)
approve the conversion of a $1,000,000 Convertible Note convertible into 717,241 shares of Common Stock, are considered “non-routine”
matters, and brokers are not entitled to vote uninstructed shares with respect to these proposals. The proposal to ratify the appointment
of Marcum, LLP, as the Company’s independent registered public accounting firm is a routine matters that brokers are entitled
to vote upon without receiving instructions.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Who is paying for this proxy solicitation?</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will pay for the entire cost of soliciting
proxies. In addition to these mailed proxy materials, our directors and employees may also solicit proxies in person, by telephone
or by other means of communication. Directors and employees will not be paid any additional compensation for soliciting proxies
but may be reimbursed for out-of-pocket expenses incurred in connection with the solicitation. We will also reimburse brokerage
firms, banks and other agents for their reasonable out-of-pocket expenses incurred in forwarding proxy materials to beneficial
owners</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <b>What does it mean if I receive more than one set of
proxy materials?</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If you receive more than one set of proxy
materials, your shares may be registered in more than one name or in different accounts. Please complete, sign and return each
proxy card to ensure that all of your shares are voted.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>I share the same address with another
stockholder of the Company. Why has our household only received one set of proxy materials?</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The rules of the Securities and Exchange
Commission’s (“<b>SEC</b>”) permit us to deliver a single set of proxy materials to one address shared by two
or more of our stockholders. This practice, known as “householding,” is intended to reduce the Company’s printing
and postage costs. We have delivered only one set of proxy materials to stockholders who hold their shares through a bank, broker
or other holder of record and share a single address, unless we received contrary instructions from any stockholder at that address.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>How can I find out the results of the
voting at the Special Meeting?</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Final voting results will be disclosed
in a Form 8-K filed after the Special Meeting.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Who can help answer my questions?</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You can contact our corporate headquarters,
at DPW Holdings, Inc., 201 Shipyard Way, Newport Beach, CA 92663, by sending a letter to Milton C. “Todd” Ault, III,
our Chief Executive Officer, with any questions about the proposals described in this Proxy Statement or how to execute your vote,
or by phone at (949) 444-5464. </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
<!-- Field: Page; Sequence: 11 -->
<div style="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></tbody></table></div>
<div style="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tbody><tr><td style="text-align: center; width: 100%"> </td></tr></tbody></table></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROPOSAL NO. 1 </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>APPROVAL, PURSUANT TO NYSE AMERICAN
LISTING RULE 713, OF THE ISSUANCE OF SHARES OF OUR COMMON STOCK TO ESOUSA</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are asking our stockholders to approve
the issuance of up to 26,637,684 shares of our Common Stock to Esousa pursuant to, and upon the terms and subject to the conditions
set forth in, the Master Exchange Agreement, dated February 10, 2020 (the “<b>Exchange Agreement</b>”), between the
Company and Esousa, an entity that acquired approximately $4.2 million dollars in principal amount, plus accrued but unpaid interest,
of certain promissory notes that had been previously issued by the Company to Dominion Capital, LLC, a Connecticut limited liability
company (the “<b>Dominion Note</b>”), and the Canadian Special Opportunity Fund, LP (the “<b>CSOF Note</b>”
and with the Dominion Note, the “<b>Purchased Notes</b>”) in separate transactions. Esousa also agreed to purchase
additional notes up to an additional principal amount, plus accrued but unpaid interest, of $3.5 million (the “<b>Additional
Notes</b>” and collectively, with the Purchased Notes, the “<b>Notes</b>”), prior to the second pricing period
discussed below (the “<b>Second Purchase</b>”). Pursuant to the Exchange Agreement, Esousa has the unilateral right
to acquire, among other things set forth therein, shares of the Company’s Common Stock (the “<b>Exchange Shares</b>”)
in exchange for the Notes, which Notes evidence an aggregate of up to approximately $7.7 million of indebtedness of the Company.
The Exchange Agreement also provides that we may issue shares to Esousa to the extent that after giving effect to such issuance,
Esousa would not beneficially own in excess of a maximum percentage of 4.99% of the Common Stock (the “<b>Maximum Percentage</b>”),
as such Maximum Percentage may be adjusted. In addition, we may not issue additional shares to Esousa which would exceed 19.9%
of the total number of shares of Common Stock outstanding as of the date of the Exchange Agreement (or 861,580 shares) unless we
have obtained stockholder approval of the issuance of more than such number of shares in exchange for the Additional Notes, as
required by Rule 713(a)(ii) of the NYSE Company Guide, and subsequently, authorization from the NYSE American (together, the “<b>Required
Approvals</b>”). Esousa also received warrants to purchase 1,832,597 shares of Common Stock (the “<b>Purchase Warrant</b>”)
at an exercise price equal to $1.43 per share of Common Stock, and the exercise of the Warrant is also subject to the Maximum Percentage.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are seeking stockholder approval for
the issuance of shares in excess of 19.9% of the total number of shares of Common Stock outstanding as of the date of the Exchange
Agreement. If this Proposal is not approved by our stockholders, the Company will not be able to issue additional shares to Esousa
under the Exchange Agreement, and the Company anticipates it would need to seek alternative methods of repaying the promissory
notes underlying the Exchange Agreement, which may include additional transactions with Esousa. Ault &amp; Company, Inc. whose
Chief Executive Officer is Milton C. Ault, the Company’s Chief Executive Officer and Chairman of the Board, has entered into
a voting agreement with Esousa pursuant to which it has agreed to vote its shares in favor of this Proposal 1.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Overview of Exchange Agreement</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 10, 2020, the Company entered
into the Exchange Agreement with Esousa. Pursuant to the Exchange Agreement, Esousa has the unilateral right to acquire the Exchange
Shares. Subsequent to the effective date of the Exchange Agreement, Esousa exchanged a portion of the Dominion Note for a limited
number of Exchange Shares (the “<b>Initial Exchange</b>”), and the second exchange (the “<b>Second Exchange</b>”
and together with the Initial Exchange, the “<b>Exchange</b>”) shall occur if, within sixty days after the Initial
Exchange, the Company receives the Required Approvals.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Exchange Agreement provides for two
pricing periods (each a “<b>Pricing Period</b>”), the first of which shall commence after the date on which Esousa
receives the Exchange Shares pursuant to the Initial Exchange and ending on the date that is 90 days after such receipt thereof,
subject to extension as provided for in the Exchange Agreement, and the second of which shall commence on the date on which Esousa
receives the Exchange Shares pursuant to the Second Exchange and ending on the date that is 90 days after such receipt thereof,
in either case, unless earlier terminated by Esousa by written notice.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During each pricing period, Esousa will
have the unilateral right to exchange the Notes for shares of the Company’s Common Stock, or the Exchange Shares. The number
of shares to be issued upon each Exchange will be equal to (x) the principal and accrued but unpaid interest due on the Notes being
exchanged multiplied by 1.35, divided by (y) the closing bid price effective on each date of an exchange notice pursuant to Section
3(a)(9) of the Securities Act of 1933, as amended (the “<b>Securities Act</b>”), provided, however, that the Company
shall theretofore have obtained the Required Approvals (the “<b>Exchange Price</b>”). The total number of shares of
the Company’s Common Stock to be issued to Esousa in connection with the applicable Exchange shall be adjusted on the business
day immediately following the Pricing Period based upon the volume weighted average price (“<b>VWAP</b>”) of the Company’s
Common Stock over the applicable Pricing Period (the “<b>VWAP Shares</b>”). VWAP Shares means the number of shares
determined by dividing (x) the Exchange Amount of the applicable Exchange, multiplied by 1.1, by (y) the greater of (I) seventy-five
percent (75.0%) of the VWAP of the Company’s Common Stock over the applicable Pricing Period, or (II) $0.30 per share.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a result of the Initial Exchange, Esousa
acquired the Purchased Notes under the Exchange Agreement in exchange for approximately $4.2 million. The Second Exchange for the
remaining Notes in the approximate amount of $3.5 million will occur promptly following obtaining the Required Approvals. If our
stockholders do not approve this Proposal 1, neither the second Pricing Period nor the Second Exchange will occur.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>
<!-- Field: Page; Sequence: 12 -->
<div style="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></tbody></table></div>
<div style="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tbody><tr><td style="text-align: center; width: 100%"> </td></tr></tbody></table></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Esousa does not have the right to exchange
Notes for shares of our Common Stock to the extent that following such exchange Esousa would beneficially own in excess of 4.9%
of our Common Stock, of the Maximum Percentage, as determined in accordance with Section 13(d) of the Securities Exchange Act of
1934, as amended. In addition, under no circumstances may the aggregate number of shares of Common Stock issued to Esousa in connection
with the exchange of the Notes at any time exceed 861,580 shares, which is equal to 19.9% of the total number of shares of our
Common Stock outstanding as of the date of the Exchange Agreement, unless we have obtained stockholder approval of the issuance
of more than such number of shares pursuant to Rule 713 of the NYSE American.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the Exchange Agreement,
the Company also issued to Esousa the Purchase Warrant to purchase shares of the Company’s Common Stock equal to (i) the
amount of the Additional Notes, multiplied by 0.83, and divided by (ii) the closing bid price of the Company’s Common Stock
as of the date immediately prior to the Initial Exchange, or $1.30. The Purchase Warrant shall be exercisable, commencing on the
date upon which the Company’s receives the Required Approvals thereof, for the exercise price of one hundred ten percent
(110%) of the closing bid price of the Company’s Common Stock as of the date immediately prior to the Initial Exchange, or
$1.43. In connection therewith, the Company has agreed to file a registration statement to register the sale of the shares of Common
Stock underlying the exercise of the Purchase Warrant by Esousa pursuant to the Exchange Agreement. In the event that Esousa does
not purchase all of the Additional Notes, the Company shall have the option to acquire a portion of the Purchase Warrants from
Esousa for an aggregate price of $1.00. The Purchase Warrant may be exercised for cash. Upon the failure by the Company to maintain
an effective registration statement as set forth in the Exchange Agreement, the Company shall incur penalties for each month that
the SEC fails to declare such registration statement effective.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The shares issued under the Exchange Agreement
have been or will be issued pursuant to the exemption from registration set forth in Section 3(a)(9) of the Securities Act, which
permits an issuer to exchange new securities for existing securities exclusively where no commission or other remuneration is paid
or given directly or indirectly for soliciting such exchange.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Exchange Agreement contains customary
representations, warranties and covenants by the parties. Among other covenants, neither the Company nor any of its subsidiaries
may, directly or indirectly, issue any equity security or any equity-linked or related security until 30 days after the date of
the Second Exchange. In the event there is no Second Exchange, such restriction shall lapse 30 days after the end of the Pricing
Period applicable to the Initial Exchange. Moreover, during the period commencing on the date of the Exchange Agreement and ending
on the later of (i) 10 calendar days after the end of the Pricing Period or (ii) such time as when all of the Notes have been exchanged
or repaid, the Company may not directly or indirectly issue equity or debt securities of the Company to a party in exchange for
outstanding equity or debt securities in one or more transactions carried out pursuant to Section 3(a)(9) or Section 3(a)(10) of
the Securities Act, unless the Company has received prior written consent from Esousa. In addition, the Company has agreed to indemnify
Esousa and its affiliates for material misstatements or breaches of its obligations under the Exchange Agreement.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A copy of the Exchange Agreement is attached
as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on February 10, 2020.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Stockholder Approval Requirement</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As noted above, the Exchange Agreement
provides that the number of shares to be issued to Esousa is initially limited to 19.9% of the total number of shares of Common
Stock outstanding as of the date of the Exchange Agreement until such time as the stockholders of the Company approve the issuance
of additional shares, which include the shares underlying the Purchase Warrant. We have agreed to promptly seek such stockholder
approval and are seeking such approval at the Special Meeting.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Rule 713 of the NYSE American requires
stockholder approval of a transaction, other than a public offering, involving the sale, issuance or potential issuance by an issuer
of Common Stock (or securities convertible into or exercisable for Common Stock) at a price less than the greater of book or market
value which together with sales by officers, directors or principal stockholders of the issuer equals 20% or more of presently
outstanding Common Stock, or equal to 20% or more of presently outstanding stock for less than the greater of book or market value
of the stock, or when the issuance or potential issuance of additional shares will result in a change of control of the issuer.
Stockholder approval of this Proposal 1 will constitute stockholder approval for purposes of Rule 713 of the NYSE American.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are seeking stockholder approval for
the issuance of up to 26,637,684 shares of our Common Stock to Esousa in connection with the exchange of the Notes and the
exercise of the Purchase Warrant. We will seek additional stockholder approval before issuing shares in excess of that number.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If our stockholders do not approve this
Proposal, the Company will need to find alternative means of refinancing or extending the Notes, and the Company may not be successful
in such efforts. If the Company is unable to refinance or extend the Notes, the Company may default on the Notes, which would materially
adversely affect the Company and could result in severe curtailment of the Company’s activities and the insolvency of the
Company.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>
<!-- Field: Page; Sequence: 13 -->
<div style="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></tbody></table></div>
<div style="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tbody><tr><td style="text-align: center; width: 100%"> </td></tr></tbody></table></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our stockholders are not entitled to dissenters’
rights with respect to this Proposal, and we will not independently provide stockholders with any such right.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Reasons for Transaction</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">After considering various alternative transactions,
including potential capital raises and extensions of or refinancing the Notes, the Board of Directors determined that the Exchange
Agreement with Esousa is in the best interests of the Company and its stockholders because it permits the Company to issue equity
in exchange for the $7,700,000 due under the Notes.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Exchange Agreement eliminates debt
in which the Company was in default and the Company believes the impact of the Exchange Agreement should also improve the Company’s
financial results by reducing the Company’s borrowing costs and enabling management to focus on growing the Company’s
business, which was challenging in light of the constraints under the Company’s prior debt agreements.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Effect on Current Stockholders; Dilution</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Exchange Agreement does not affect
the rights of the holders of outstanding Common Stock, but the issuance of shares to Esousa pursuant to the terms of
the Exchange Agreement will have a dilutive effect on our existing stockholders, including the voting power and the economic rights
of the existing stockholders. We issued Esousa all 861,580 shares it was entitled to acquire absent stockholder approval; had it
sold no such shares, that figure would have consisted of approximately 14.9% of the 5,771,634 shares outstanding as of the
Record Date.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The availability for sale of a large amount
of shares by Esousa may depress the market price of our Common Stock and, going forward, may impair our ability to raise additional
capital through the public sale of our Common Stock. We do not have any arrangement with Esousa to address the possible effect
on the price of our Common Stock of the sale by Esousa of its shares.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As noted above, the Exchange Agreement
provides that the Company shall not issue, and Esousa shall not acquire, any shares of our Common Stock under the Exchange Agreement
if such shares proposed to be issued and sold, when aggregated with all other shares of our Common Stock then owned beneficially
(as calculated pursuant to Section 13(d) of the Securities Exchange Act of 1934, as amended) by Esousa and its affiliates, would
result in the beneficial ownership by Esousa and its affiliates in excess of the Maximum Percentage. This beneficial ownership
limitation limits the number of shares Esousa may beneficially own at any one time to 4.9% of our outstanding Common Stock. Consequently,
the number of shares Esousa may beneficially own in compliance with the beneficial ownership limitation may increase over time
as the number of outstanding shares of our Common Stock increases over time. Esousa may sell some or all of the shares it acquires
under the Exchange Agreement, subject to Esousa’s compliance with the Securities Act and applicable state law. Even though
Esousa’s beneficial ownership of our Common Stock is subject to the Maximum Percentage, Esousa may be in a position to exert
influence over the Company and there is no guarantee that the interests of Esousa will align with the interests of other stockholders.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Required Vote
and Board Recommendation</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The issuance of shares to Esousa requires
the receipt of the affirmative vote of a majority of the shares of the Company’s Common Stock present in person or by proxy
and voting at the Special Meeting.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>The Board unanimously recommends a vote
“FOR” the approval of the issuance of shares of Common Stock to Esousa in order to comply with Rule 713 of the NYSE
American.</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>
<!-- Field: Page; Sequence: 14 -->
<div style="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></tbody></table></div>
<div style="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tbody><tr><td style="text-align: center; width: 100%"> </td></tr></tbody></table></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROPOSAL NO. 2</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>APPROVAL OF THE EXERCISE OF WARRANTS
TO PURCHASE UP TO 2,000,000 SHARES OF COMMON STOCK IN ORDER TO COMPLY WITH RULE 713 OF THE NYSE AMERICAN</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Terms of the Transaction</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company may issue one or more 12% Secured
Promissory Term Notes (the “<b>Esousa Notes</b>”) to Esousa Holdings, LLC (“<b>Esousa</b>”) before the
date of the Special Meeting in an aggregate amount of up to $2,000,000 and will in no event issue any such notes beyond June 29,
2020, which is 90 days from the date of the Special Meeting. In connection with issuance any such Esousa Notes, the Company has
agreed to issue Esousa warrants to purchase that number of shares of Common Stock equal to the principal amount of the aggregate
amount of the Esousa Notes divided by the closing market price of the shares of Common Stock on the date that a particular Esousa
Note was purchased, subject to a floor of $1.00.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Description of the Warrants </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Esousa will in connection with the purchase
of the Esousa Notes be issued the warrants described above (the “<b>Esousa Warrants</b>”) to purchase that number of
shares of Common Stock equal to the principal amount of the aggregate amount of the Esousa Notes divided by the closing market
price of the shares of Common Stock on the date that a particular Esousa Note was purchased, subject to a floor of $1.00. The Esousa
Warrants will be exercisable at a price equal to 110% of the closing market price of the shares of Common Stock on the date that
a particular Esousa Note was purchased and be exercisable for a period of five years from their issuance date. The exercise price
of the Esousa Warrants shall be subject to adjustment for customary stock splits, stock dividends, combinations or similar events.
The Company intend to use any proceeds it may receive from the exercise of the Esousa Warrants for general working capital purposes.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Why the Company Needs Stockholder Approval</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Rule 713 of the NYSE American requires
stockholder approval of a transaction, other than a public offering, involving the sale, issuance or potential issuance by an issuer
of Common Stock (or securities convertible into or exercisable for Common Stock) at a price less than the greater of book or market
value which together with sales by officers, directors or principal stockholders of the issuer equals 20% or more of presently
outstanding Common Stock, or equal to 20% or more of presently outstanding stock for less than the greater of book or market value
of the stock, or when the issuance or potential issuance of additional shares will result in a change of control of the issuer.
The exercise price of the Esousa Warrants will be lower than the market price of our Common Stock on the issuance dates of the
Esousa Notes and may be lower than the market price upon exercise. Accordingly, Esousa is prohibited from exercising the Esousa
Warrants and receiving shares of our Common Stock unless stockholder approval is obtained for the Esousa Warrants.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Effect of Proposal on Current Stockholders</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Proposal No. 2 is adopted,
up to 2,000,000 shares of Common Stock would be issuable. Based on the number of shares of Common Stock outstanding as of the Record
Date, such shares would represent 28.80% of our total outstanding shares (giving effect to such issuance). The issuance of such
shares may result in significant dilution to our stockholders and afford them a smaller percentage interest in the voting power,
liquidation value and aggregate book value of the Company. The sale or any resale of the Common Stock issued upon exercise of the
Esousa Warrants could cause the market price of our Common Stock to decline as well as result in substantial dilution to other
stockholders since Esousa may ultimately exercise and sell the full amount issuable on exercise. This means that our current stockholders
will own a smaller interest in our Company and will have less ability to influence significant corporate decisions requiring stockholder
approval.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Required Vote and Board Recommendation</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The exercise of the Esousa Warrants requires
the receipt of the affirmative vote of a majority of the shares of the Company’s Common Stock present in person or by proxy
and voting at the Special Meeting.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>The Board unanimously recommends a vote
“FOR” the approval issuance of Common Stock upon of the exercise the Esousa Warrants for up to 2,000,000 shares of
Common Stock in order to comply with Rule 713 of the NYSE American.</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>
<!-- Field: Page; Sequence: 15 -->
<div style="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></tbody></table></div>
<div style="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tbody><tr><td style="text-align: center; width: 100%"> </td></tr></tbody></table></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROPOSAL NO. 3</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>APPROVAL OF THE CONVERSION OF A $1,000,000
CONVERTIBLE PROMISSORY NOTE INTO 717,241 SHARES OF COMMON STOCK IN ORDER TO COMPLY WITH RULE 713 OF THE NYSE AMERICAN</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Terms of the Transaction</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 5, 2020, we sold an 8% Convertible
Promissory Note (the “<b>Ault Note</b>”) to Ault &amp; Company. As described further below, the principal of the Ault
Note may be converted into shares of Common Stock at a conversion price of $1.45 per share.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Ault Note is in the principal amount
of $1,000,000 and was sold for $1,000,000, bears interest at 8% simple interest on the principal amount, and is due on August 5,
2020 (the “<b>Maturity Date</b>”). The principal and accrued interest thereon may be converted into our shares of Common
Stock at $1.45 per share. Commencing on the date that the approval of the Company’s stockholders of this Proposal is obtained,
as required by Rule 713(a)(ii) of the NYSE Company Guide, Ault &amp; Company may convert the principal amount of the Ault Note
at any time into Common Stock. The conversion price of the Ault Note is subject to adjustment for customary stock splits, stock
dividends, combinations or similar events. Assuming the Ault Note is converted into shares of Common Stock on the Maturity Date,
we would issue to Ault &amp; Company a number of shares of Common Stock equal to $1,000,000 in principal plus interest of $40,000
divided by $1.45, or 717,241 such shares.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Why the Company Needs Stockholder Approval</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Rule 713 of the NYSE American requires
stockholder approval of a transaction, other than a public offering, involving the sale, issuance or potential issuance by an issuer
of Common Stock (or securities convertible into or exercisable for Common Stock) at a price less than the greater of book or market
value which together with sales by officers, directors or principal stockholders of the issuer equals 20% or more of presently
outstanding Common Stock, or equal to 20% or more of presently outstanding stock for less than the greater of book or market value
of the stock, or when the issuance or potential issuance of additional shares will result in a change of control of the issuer.
The initial conversion price of the Ault Note was equal to the market price of our Common Stock on the day immediately prior to
execution date of the Ault Note. Accordingly, Ault &amp; Company is prohibited from converting the Ault Note and receiving shares
of our Common Stock unless stockholder approval is obtained for the Ault Note.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Effect of Proposal on Current Stockholders</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Proposal No. 3 is adopted,
based on the conversion of the Ault Note, up to 717,241 shares of Common Stock would be issuable. Based on the number of shares
of Common Stock outstanding as of the Record Date, such shares would represent 11.1% of our total outstanding shares (giving effect
to such issuance). The issuance of such shares may result in significant dilution to our stockholders and afford them a smaller
percentage interest in the voting power, liquidation value and aggregate book value of the Company. The sale or any resale of the
Common Stock issued upon conversion of the Ault Note could cause the market price of our Common Stock to decline as well as result
in substantial dilution to other stockholders since Ault &amp; Company may ultimately convert and sell the full amount issuable
on conversion and exercise. This means that our current stockholders will own a smaller interest in our Company and will have less
ability to influence significant corporate decisions requiring stockholder approval.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Further Information.</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The terms of the Ault Note are complex
and only briefly summarized above. For further information, please refer to the descriptions contained in the Company’s Current
Report on Form 8-K filed with the SEC on February 6, 2020, and the transaction documents filed as exhibits to such report. The
discussion herein is qualified in its entirety by reference to such filed transaction documents.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Required Vote and Board Recommendation</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The conversion of the Ault Note requires
the receipt of the affirmative vote of a majority of the shares of the Company’s Common Stock present in person or by proxy
and voting at the Special Meeting.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>The Board unanimously recommends a vote “FOR”
the approval issuance of 717,241 shares of Common Stock upon of the conversion of the Ault Note in order to comply with Rule
713 of the NYSE American.</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>
<!-- Field: Page; Sequence: 16 -->
<div style="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></tbody></table></div>
<div style="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tbody><tr><td style="text-align: center; width: 100%"> </td></tr></tbody></table></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROPOSAL NO. 4</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>RATIFICATION OF APPOINTMENT OF OUR INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Audit Committee has appointed the firm
of Marcum LLP, as the independent registered public accounting firm of the Company for the year ending December 31, 2020, subject
to ratification of the appointment by the Company’s stockholders. No representative of Marcum LLP is expected to attend the
Meeting.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Review of the Company’s Audited
Financial Statements for the Fiscal Year Ended December 31, 2019</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Audit Committee met and held discussions
with management and the independent auditors. Management represented to the Audit Committee that the Company’s consolidated
financial statements were prepared in accordance with accounting principles generally accepted in the United States, and the Audit
Committee reviewed and discussed the consolidated financial statements with management and the independent auditors. The Audit
Committee also discussed with the independent auditors the matters required to be discussed by Statement on Auditing Standards
No. 114 (Codification of Statements on Auditing Standards, AU 380), as amended.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, the Audit Committee discussed
with the independent auditors the auditors’ independence from the Company and its management, and the independent auditors
provided to the Audit Committee the written disclosures and letter required by the Independence Standards Board Standard No. 1
(Independence Discussions With Audit Committees).</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Audit Committee discussed with the
Company’s independent auditors the overall scope and plans for their respective audits. The Audit Committee met with the
independent auditors, with and without management present, to discuss the results of their examinations and the overall quality
of the Company’s internal controls and financial reporting.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Based on the reviews and discussions referred
to above, the Audit Committee approved the audited financial statements be included in the Company’s Annual Report on Form
10-K for the year ended December 31, 2019 for filing with the SEC.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Fees Paid to Auditors</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Audit Fees</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The aggregate fees billed for each of the
last two fiscal years for professional services rendered by the principal accountants Marcum, LLP, with respect to the years ended
December 31, 2019 and December 31, 2018, for our audit of annual financial statements and review of financial statements included
in our quarterly reports or services that are normally provided by the accountant in connection with statutory and regulatory filings
or engagements for those fiscal years were:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse">
<tbody><tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="width: 87%">2019</td>
<td style="width: 1%"> </td>
<td style="width: 1%">$</td>
<td style="width: 10%"><p style="margin: 0pt 0; text-align: right">775,620</p>
</td>
<td style="white-space: nowrap; width: 1%"> </td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td>2018</td>
<td> </td>
<td>$</td>
<td style="text-align: right">610,564</td>
<td style="white-space: nowrap"> </td></tr>
</tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27.5pt"><b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Audit-Related Fees</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We did not incur fees to our independent
registered public accounting firm for audit related fees during the fiscal years ended December 31, 2019 and 2018.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Tax and Other Fees</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We did not incur fees to our independent
registered public accounting firm for tax services during the fiscal years ended December 31, 2019 and 2018.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Pre-Approval Policies and Procedures</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Consistent with SEC policies and guidelines
regarding audit independence, the Audit Committee is responsible for the pre-approval of all audit and permissible non-audit services
provided by our principal accountants on a case-by-case basis. Our Audit Committee has established a policy regarding approval
of all audit and permissible non-audit services provided by our principal accountants. Our Audit Committee pre-approves these services
by category and service. Our Audit Committee has pre-approved all of the services provided by our principal accountants.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
<!-- Field: Page; Sequence: 17 -->
<div style="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></tbody></table></div>
<div style="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tbody><tr><td style="text-align: center; width: 100%"> </td></tr></tbody></table></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>REPORT OF THE AUDIT COMMITTEE OF THE
BOARD OF DIRECTORS</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><i> </i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>The Audit Committee
of the Board of DPW Holdings, Inc. has furnished the following report on its activities during the fiscal year ended December 31,
2019. The report is not deemed to be “soliciting material” or “filed” with the SEC or subject to the SEC’s
proxy rules or to the liabilities of Section 18 of the Exchange Act, and the report shall not be deemed to be incorporated by reference
into any prior or subsequent filing under the Securities Act of 1933, as amended (the “<b>Securities Act</b>”), or
the Exchange Act, except to the extent that DPW Holdings, Inc. specifically incorporates it by reference into any such filing.</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Audit Committee
oversees the financial reporting process on behalf of the Board. Management has the primary responsibility for the financial reporting
process, principles and internal controls as well as preparation of our financial statements. For the fiscal year ended December
31, 2019, the members of the Audit Committee were Messrs. Smith, Rosenberg and Bentz, each of whom was an independent director
as defined by the applicable NYSE American and SEC rules.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In fulfilling
its responsibilities, the Audit Committee appointed independent auditors Marcum, LLP, for the fiscal year ended December 31, 2019.
The Audit Committee reviewed and discussed with the independent auditors the overall scope and specific plans for their audit.
The Audit Committee also reviewed and discussed with the independent auditors and with management the Company’s audited financial
statements and the adequacy of its internal controls. The Audit Committee met with the independent auditors, without management
present, to discuss the results of our independent auditor’s audits, their evaluations of the Company’s internal controls
and the overall quality of the Company’s financial reporting.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Audit Committee
monitored the independence and performance of the independent auditors. The Audit Committee discussed with the independent auditors
the matters required to be discussed by Public Company Accounting Oversight Board (“<b>PCAOB</b>”) Auditing Standard
No. 16—Communications with Audit Committees. The Company’s independent auditors have provided the Audit Committee with
the written disclosures and the letter required by applicable requirements of the PCAOB regarding the independent auditors’
communications with the Audit Committee concerning independence, and the Audit Committee has discussed with the independent auditor
the independent auditor’s independence. Based upon the review and discussions referred to above, the Audit Committee recommended
to the Board that the audited financial statements be included in the Annual Report on Form 10-K for the fiscal year ended December
31, 2019, for filing with the SEC.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white"><i>Mr. Robert
O. Smith, Mr. Moti Rosenberg, Mr. Jeffrey Bentz</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Required Vote
and Board Recommendation</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The ratification of the appointment of
the Company’s independent auditors requires the receipt of the affirmative vote of a majority of the shares of the Company’s
Common Stock present in person or by proxy and voting at the Meeting.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>The Board unanimously recommends that
the stockholders vote “for” the ratification of Marcum LLP, as the Company’s independent registered public accounting
firm for the year ending December 31, 2020.</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>
<!-- Field: Page; Sequence: 18 -->
<div style="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></tbody></table></div>
<div style="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tbody><tr><td style="text-align: center; width: 100%"> </td></tr></tbody></table></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL
OWNERS AND MANAGEMENT</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Except as otherwise indicated below, the
following table sets forth certain information regarding beneficial ownership of our common stock as of the Record Date by (1)
each of our current directors; (2) each of the executive officers; (3) each person known to us to be the beneficial owner of more
than 5% of the outstanding shares of our common stock based upon Schedules 13G or 13D filed with the SEC; and (4) all of our directors
and executive officers as a group. As of the Record Date, there were 5,771,634 shares of our common stock issued and outstanding.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Beneficial ownership is determined in
accordance with the rules of the SEC and includes voting or investment power with respect to the securities. Common stock
subject to options or warrants that are currently exercisable or exercisable within 60 days of the Record Date are deemed to
be outstanding and to be beneficially owned by the person or group holding such options or warrants for the purpose of
computing the percentage ownership of such person or group, but are not treated as outstanding for the purpose of computing
the percentage ownership of any other person or group. Unless otherwise indicated by footnote, to our knowledge, the persons
named in the table have sole voting and sole investment power with respect to all common stock shown as beneficially owned by
them, subject to applicable community property laws. Unless otherwise indicated below, the address of each beneficial owner
listed below is c/o DPW Holdings, Inc., 201 Shipyard Way, Newport Beach, California 92663.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tbody><tr>
<td style="border-bottom: Black 1pt solid; white-space: nowrap"><b>Name and address of beneficial owner</b></td>
<td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom"> </td>
<td colspan="3" style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Number of</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>shares</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>beneficially</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>owned</b></p></td>
<td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom"> </td>
<td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Approximate</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Percent</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>of class</b></p></td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td><b><u>Greater than 5% Beneficial Owners</u></b>:</td>
<td> </td>
<td style="text-align: right"> </td>
<td style="text-align: right"> </td>
<td style="white-space: nowrap; text-align: right"> </td>
<td style="width: 3%; text-align: right"> </td>
<td style="width: 13%; text-align: right"> </td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td>Ault &amp; Company, Inc.</td>
<td> </td>
<td style="text-align: right"> </td>
<td style="text-align: right"> </td>
<td style="white-space: nowrap; text-align: right">673,140</td>
<td style="text-align: right"><sup>(2)</sup></td>
<td style="text-align: right">11.7%</td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td><b><u>Directors and executive officers: <sup>(1)</sup></u></b></td>
<td> </td>
<td style="text-align: right"> </td>
<td style="text-align: right"> </td>
<td style="white-space: nowrap; text-align: right"> </td>
<td style="text-align: right"> </td>
<td style="text-align: right"> </td></tr>
<tr style="background-color: #CCEEFF">
<td>Milton Ault, III</td>
<td style="vertical-align: bottom"> </td>
<td style="vertical-align: top; text-align: right"> </td>
<td style="vertical-align: bottom; text-align: right"> </td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: right">673,183</td>
<td style="vertical-align: bottom; text-align: right"><sup>(3)</sup></td>
<td style="vertical-align: top; text-align: right">11.7%</td></tr>
<tr style="background-color: white">
<td>Henry Nisser</td>
<td style="vertical-align: bottom"> </td>
<td style="vertical-align: top; text-align: right"> </td>
<td style="vertical-align: bottom; text-align: right"> </td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: right">3,906</td>
<td style="vertical-align: bottom; text-align: right"><sup>(4)</sup></td>
<td style="vertical-align: top; text-align: right">*</td></tr>
<tr style="background-color: #CCEEFF">
<td>Amos Kohn</td>
<td style="vertical-align: bottom"> </td>
<td style="vertical-align: top; text-align: right"> </td>
<td style="vertical-align: bottom; text-align: right"> </td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: right">698</td>
<td style="vertical-align: bottom; text-align: right"><sup>(5)</sup></td>
<td style="vertical-align: top; text-align: right">*</td></tr>
<tr style="background-color: white">
<td>Robert Smith</td>
<td style="vertical-align: bottom"> </td>
<td style="vertical-align: top; text-align: right"> </td>
<td style="vertical-align: bottom; text-align: right"> </td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: right">108</td>
<td style="vertical-align: bottom; text-align: right"><sup>(6)</sup></td>
<td style="vertical-align: top; text-align: right">*</td></tr>
<tr style="background-color: #CCEEFF">
<td>William Horne</td>
<td style="vertical-align: bottom"> </td>
<td style="vertical-align: top; text-align: right"> </td>
<td style="vertical-align: bottom; text-align: right"> </td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: right">556</td>
<td style="vertical-align: bottom; text-align: right"><sup>(7)</sup></td>
<td style="vertical-align: top; text-align: right">*</td></tr>
<tr style="background-color: white">
<td>Mordechai Rosenberg</td>
<td style="vertical-align: bottom"> </td>
<td style="vertical-align: top; text-align: right"> </td>
<td style="vertical-align: bottom; text-align: right"> </td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: right">0</td>
<td style="vertical-align: bottom; text-align: right"> </td>
<td style="vertical-align: top; text-align: right">*</td></tr>
<tr style="background-color: #CCEEFF">
<td>Jeffrey A. Bentz</td>
<td style="vertical-align: bottom"> </td>
<td style="vertical-align: top; text-align: right"> </td>
<td style="vertical-align: bottom; text-align: right"> </td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: right">9</td>
<td style="vertical-align: bottom; text-align: right"> </td>
<td style="vertical-align: top; text-align: right">*</td></tr>
<tr style="vertical-align: bottom; background-color: white">
<td>Jodi Brichan</td>
<td> </td>
<td style="border-bottom: black 1pt solid; text-align: right"> </td>
<td style="border-bottom: black 1pt solid; text-align: right"> </td>
<td style="white-space: nowrap; border-bottom: black 1pt solid; text-align: right">0</td>
<td style="border-bottom: black 1pt solid; text-align: right"> </td>
<td style="border-bottom: black 1pt solid; text-align: right">*</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td>All directors and executive officers as a group (eight persons)</td>
<td> </td>
<td style="border-bottom: black 1pt solid; text-align: right"> </td>
<td style="border-bottom: black 1pt solid; text-align: right"> </td>
<td style="white-space: nowrap; border-bottom: black 1pt solid; text-align: right">678,460</td>
<td> </td>
<td style="border-bottom: black 1pt solid; text-align: right">11.7%</td></tr>
</tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">  </p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tbody><tr style="vertical-align: top">
<td style="width: 3.9pt"></td><td style="width: 18pt">*</td><td style="text-align: justify">Less than one percent.</td></tr></tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tbody><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">(1)</td><td style="text-align: justify">Unless otherwise indicated, the business address of each of the individuals is c/o DPW Holdings,
Inc., 201 Shipyard Way, Suite E, Newport Beach, California 92663.</td></tr></tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tbody><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">(2)</td><td style="text-align: justify">Includes shares owned by Philou Ventures of which Ault &amp; Company, Inc., is the Manager, consisting
of: (i) 125,000 shares of Series B Preferred Stock that are convertible into 2,232 shares of Common Stock, (ii) warrants to purchase
2,232 shares of Common Stock that are exercisable within 60 days of the Record Date and (iii) 3,408 shares of Common Stock. Also
includes warrants to purchase 94 shares of Common Stock that are exercisable within 60 days of the Record Date. Excludes 717,241
shares of Common Stock issuable upon conversion of the Ault Note.</td></tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="margin-top: 0; margin-bottom: 0"></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tbody><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">(3)</td><td style="text-align: justify">Mr. Ault is the Chief Executive Officer of Ault &amp; Company, Inc. Includes 673,140 shares beneficially
owned by Ault &amp; Company, which may be deemed beneficially owned by Mr. Ault. Also includes 43 shares of Common Stock. Excludes
717,241 shares of Common Stock issuable upon conversion of the Ault Note.</td></tr></tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="margin-top: 0; margin-bottom: 0"></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tbody><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">(4)</td><td style="text-align: justify">Includes 3,906 shares of Common Stock issuable pursuant to a stock incentive grant.</td></tr></tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tbody><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">(5)</td><td style="text-align: justify">Includes warrants to purchase 505 shares of Common Stock that are exercisable within 60 days of
the Record Date.</td></tr></tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tbody><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">(6)</td><td style="text-align: justify">Includes warrants to purchase 54 shares of Common Stock that are exercisable within 60 days of
the Record Date.</td></tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tbody><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">(7)</td><td style="text-align: justify">Includes 250 shares of Common Stock issuable pursuant to a stock incentive grant.</td></tr></tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
<!-- Field: Page; Sequence: 19 -->
<div style="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></tbody></table></div>
<div style="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tbody><tr><td style="text-align: center; width: 100%"> </td></tr></tbody></table></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>OTHER BUSINESS</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board knows of no business to be brought
before the Special Meeting other than as set forth above. If other matters properly come before the stockholders at the Special
Meeting, it is the intention of the persons named on the proxy to vote the shares represented thereby on such matters in accordance
with their judgment.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">By Order of the Board of Directors,</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tbody><tr style="vertical-align: top">
<td style="width: 20%; border-bottom: black 1pt solid"> /s/ <i>Milton C. Ault, III</i></td>
<td style="width: 80%"> </td></tr>
<tr style="vertical-align: top">
<td><i>Milton C. Ault, III</i></td>
<td> </td></tr>
<tr style="vertical-align: top">
<td colspan="2"><i>Chief Executive Officer and Chairman of the Board</i></td></tr>
</tbody></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">May 18, 2020</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<p style="margin: 0"> </p>
<!-- Field: Page; Sequence: 20 -->
<div style="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tbody><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></tbody></table></div>
<div style="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tbody><tr><td style="text-align: center; width: 100%"> </td></tr></tbody></table></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
<img src="proxycard1.jpg"/><p style="margin: 0"> </p>
<p style="margin: 0"></p>
<p style="font: 5pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-size: 2pt; color: White">14!!!! Using a black
Inll pen, mark your votes with an X as shown in this example. X Please do not write outside the designated areas. TE Your vote
matters - here's how to vote! You may vote online or by phone instead of mailing this card Online Go to www.envisionreports.com/DPW
or scan the 0R code — login details are located in the shaded bar below. Phone Call toll free 1-800-652-VOTE (8683) within
the USA, US territories and Canada Save paper, time and money! Sign up for electronic delivery at www.envisionreports.com/DPW
Special Meeting Proxy Card E) V IF VOTING BY MAIL, SIGN, DETACN AND RETURN THE BOTTON PORTION IN THE ENCLOSED ENVELOPE V u Proposals
— The Board of Directors recommends a vote FOR Proposals 1, Z, 3, 4 and 5. + 1. To approve, pursuant to Rule 713 of the
NYSE American, the issuance of shares of the Corporation's Class A common stock. par value $0.001 per share (“Common Stock")
to Esousa Holdings LLC (”Esousa"). in accordance with the Master Exchange Agreement dated February 10, 2020, and the
exercise of warrants issued in connection therewith. 3. To approve the conversion of a Sl,000,000 Convertible Promissory Note
issued on February 5, 2020 (the "Ault Note"), to Ault &amp; Company, |nc., which s convertible into 717,241 shares of
Common Stock at $1.45 per share (which figure presumes conversion of principal and accrued but unpaid interest as of August 5,
2020, the maturity date of the Ault Note), in order to comply with the listing rules the NYSE American. 5. The transaction of
such other business as may properly come before the Special Meeting or any adjournments or postponements thereof. For Against
Abstain For Against Abstain 2. To approve the exercise of warrants issued or issuable to U U D Esousa to purchase up to an aggregate
of 2,000,000 shares of U U D Common Stock, issued in connection with certain term promissory notes in an aggregate amount of up
to $2,000,000. 4. To ratify the appointment of Marcum LLP, as the Company's U U U independent registered public accounting firm
for the fiscal U U U year ending December 31, 2020. EIEIEI u Authorized Signatures — This section must be completed for
your vote to be counted. — Date and Sign Below Please sign exactly as name(s) appears hereon. Joint owners should each sign.
when signing as attorney, executor, administrator, corporate officer, trustee, guardian, or custodian, please give full title.
Signature 1 — Please keep signature within the box. Signature 2 — Please keep signature within the box. Date (mm/dd/VYYy)
- Please print date below. 039M5B 1UPX +</font></p>
<p style="margin: 0"> </p>
<!-- Field: Page; -->
<div style="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid">
<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
<tbody><tr style="vertical-align: top; text-align: left">
<td style="width: 33%"> </td>
<td style="width: 34%; text-align: center"></td>
<td style="width: 33%; text-align: right"> </td>
</tr>
</tbody></table>
</div>
<div style="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"></div>
<!-- Field: /Page -->
<p style="margin: 0"> </p><img src="proxycard2.jpg"/><p style="margin: 0"> </p>
<p style="margin: 0"></p>
<p style="font: 5pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-size: 2pt; color: White">The 2020 Special
Meeting of Shareholders of DPW Holdings, Inc. will be held on Monday, June 8, 2020 at 9:00am PST, virtually via the internet at
www.meetingcenter.io/266742656. To access the virtual meeting, you must have the information that is printed in the shaded bar
located on the reverse side of this form. The password for this meeting is — DPW2020. Small steps make an impact. Help the
environment by consenting to receive electronic delivery. Sign up at www.envisi0nreports.com/DPW V IF VOTING BY MAIL. SIGN, DETACH
AND RETURN TNE BOTTOM PORTION IN TNE ENCLOSED ENVELOPE V Proxy — DPW HOLDINGS, INC. + 201 Shipyard Way Newport Beach, CA
92663 (949) 444-5464 THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS The undersigned hereby appoints Milton "Todd"
Ault, ill and William B. Horne, or any one of them, as proxy, with full power to appoint substitutes, and hereby authorizes Messrs.
Ault and Horne, or any one of them, to represent and to vote as designated below, all the shares of common stock of DPW Holdings,
Inc., held of record by the undersigned as of May ll, 2020, at the 2020 Special Meeting of Stockholders to beheld virtually, at
9 a.m. Pacific Time, on June 8, 2020, and any adjournments or postponements thereof, and hereby ratifies all that said proxies
may do by virtue hereof. THIS PROXY, WHEN PROPERLY EXECUTED, WILL BE VOTED IN THE MANNER DIRECTED HEREIN BY THE UNDERSIGNED STOCKHOLDER.
IF NO DIRECTION IS MADE, THIS PROXY WILL BE VOTED FOR PROPOSALS l, 2, 3, 4 AND 5. THE PROXY HOLDER WILL HAVE DISCRETIONARY AUTHORITY
TO VOTE WITH RESPECT TO OTHER BUSINESS WHICH PROPERLY MAY COME BEFORE THE MEETING, OR ANY ADJOURNMENTS OR POSTPONEMENTS THEREOF
PLEASE READ, SIGN, DATE AND RETURN THIS PROXY PROMPTLY USING THE ENCLOSED ENVELOPE. (IF YOU VOTE BY INTERNET, PLEASE DO NOT MAILBACK
THIS PROXY CARD). THE UNDERSIGNED HEREBY ACKNOWLEDGES RECEIPT OF THE NOTICE OF SPECIAL MEETING AND PROXY STATEMENT FURNISHED IN
CONNECTION THEREWITH. H Non-Voting Items Change oi Address - Please print new address below. I +</font></p>
<p style="margin: 0"> </p>
<!-- Field: Page; -->
<div style="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid">
<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
<tbody><tr style="vertical-align: top; text-align: left">
<td style="width: 33%"> </td>
<td style="width: 34%; text-align: center"></td>
<td style="width: 33%; text-align: right"> </td>
</tr>
</tbody></table>
</div>
<div style="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"></div>
<!-- Field: /Page -->
<p style="margin: 0"> </p><img src="proxycard3.jpg"/><p style="margin: 0"> </p>
<p style="margin: 0"></p>
<p style="font: 5pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-size: 2pt; color: White">DPW HOLDINGS VOTE
Using a black Ink pen, mark your votes with an X as shown in this example. X Please do not write outside the designated areas.
Special Meeting Proxy Card V IF VOTING BY MAIL, SIGN, DETACN AND RETURN TNE BOTTON PORTION IN THE ENCLOSED ENVELOPE. V u Proposals
— The Board of Directors recommends a vote FOR Proposals 1, Z, 3, 4 and 5. + For Against Abstain For Against Abstain l.
To approve, pursuant to Rule 713 of the NYSE American, the 2 To approve the exercise of warrants issued or issuable to issuance
of shares of the Corporation's Class A common stock, U U U ‘ Esousa to purchase up to an aggregate of 2,000,000 shares of
U U D par value $0.001 per share (“Common Stock") to Esousa Common Stock, issued in connection with certain term Holdings
LLC (”Esousa"). in accordance with the Master promissory notes in an aggregate amount of up to $2,000,000. Exchange
Agreement dated February l0, 2020, and the exercise of warrants issued in connection therewith. 3. To approve the conversion of
a $1,000,000 Convertible 4. To ratify the appointment of Marcum LLP, as the Company's Promissory Note issued on February 5, 2020
(the "Ault Note"), U U U independent registered public accounting firm for the fiscal U U U to Ault &amp; Company, |nc.,
which s convertible into 717,241 shares year ending December 31, 2020. of Common Stock at $1.45 per share (which figure presumes
conversion of principal and accrued but unpaid interest as of August 5, 2020, the maturity date of the Ault Note), in order to
comply with the listing rules the NYSE American. 5. The transaction of such other business as may properly come before the Special
Meeting or any adjournments or U D U postponements thereof. u Authorized Signatures — This section must be completed for
your vote to be counted. — Date and Sign Below Please sign exactly as namets) appears hereon. Joint owners should each sign.
when signing as attorney, executor, administrator, corporate officer, trustee, guardian, or custodian, please give full title
Date (mm/dd/VYYy) — Please print date below. Signature 1 — Please keep signature within the box. Signature 2 —
Please keep signature within the box. I 1 u P x + D39M6B</font></p>
<p style="margin: 0"> </p>
<!-- Field: Page; -->
<div style="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid">
<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt">
<tbody><tr style="vertical-align: top; text-align: left">
<td style="width: 33%"> </td>
<td style="width: 34%; text-align: center"></td>
<td style="width: 33%; text-align: right"> </td>
</tr>
</tbody></table>
</div>
<div style="page-break-before: always; margin-top: 6pt; margin-bottom: 8pt"></div>
<!-- Field: /Page -->
<p style="margin: 0"> </p><img src="proxycard4.jpg"/><p style="margin: 0"> </p>
<p style="margin: 0"></p>
<p style="font: 5pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-size: 2pt; color: White">The 2020 Special
Meeting of Shareholders of DPW Holdings, Inc. will be held on Monday, June 8, 2020 at 9:00am PST, virtually via the internet at
www.meetingcenter.io/266742656. To access the virtual meeting, you must refer to the "Ouestions and Answers About the Annual
Meeting" section of the Proxy Statement. The password for this meeting is — DPW2020. v IF vormc av MAIL. SIGN, DHACH
mo RETURN THE sorrow PORTION IN THE ENCLOSED ENVELOPE v Proxy — DPW HOLDINGS, INC. 201 Shipyard Way Newport Beach, CA 92663
(949) 444-5464 THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS The undersigned hereby appoints Milton "Todd"
Ault, ill and William B. Horne, or any one of them, as proxy, with full power to appoint substitutes, and hereby authorizes Messrs.
Ault and Horne, or any one of them, to represent and to vote as designated below, all the shares of common stock of DPW Holdings,
Inc., held of record by the undersigned as of May 11, 2020, at the 2020 Special Meeting of Stockholders to beheld virtually, at
9 a.m. Pacific Time, on June 8, 2020, and any adjournments or postponements thereof, and hereby ratifies all that said proxies
may do by virtue hereof. THIS PROXY, WHEN PROPERLY EXECUTED, WILL BE VOTED IN THE MANNER DIRECTED HEREIN BY THE UNDERSIGNED STOCKHOLDER.
IF NO DIRECTION IS MADE, THIS PROXY WILL BE VOTED FOR PROPOSALS I, 2, 3, 4 AND 5. THE PROXY HOLDER WILL HAVE DISCRETIONARY AUTHORITY
TO VOTE WITH RESPECT TO OTHER BUSINESS WHICH PROPERLY MAY COME BEFORE THE MEETING, OR ANY ADJOURNMENTS OR POSTPONEMENTS THEREOF
PLEASE READ, SIGN, DATE AND RETURN THIS PROXY PROMPTLY USING THE ENCLOSED ENVELOPE. THE UNDERSIGNED HEREBY ACKNOWLEDGES RECEIPT
OF THE NOTICE OF SPECIAL MEETING AND PROXY STATEMENT FURNISHED IN CONNECTION THEREWITH. </font></p>
<p style="margin: 0"> </p>
<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><div style="font-size: 1pt; border-top: Black 2px solid"> </div></div><!-- Field: /Rule-Page -->
</text></body></html>